← Leaderboards
Yong-Hui Jiang
Yale University
$21,111,385
Attributed
$46,675,067
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.2M · FY2012–25$20M$15M$10M$5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,675,067 · 10
By mechanism
UG3$26,526,303 · 1
R01$17,191,379 · 5
U01$1,674,968 · 1
R21$1,282,417 · 3
Top collaborators
- Jian Jin6 shared
- Simon G Gregory5 shared
- Sheryl S Moy5 shared
- Ira M Hall4 shared
- Uma Reddy4 shared
- Hugh S Taylor4 shared
- Elizabeth Mara Berry-Kravis3 shared
- Jiangbing Zhou3 shared
Most similar at Yale University
Same institution · by research overlap
- Martina Brueckner$14,979,035
- Matthew W State$28,201,965
- Joseph F. Cubells$7,878,696
- Elizabeth B. Claus$21,096,464
- Justin Lee Cotney$8,490,000
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMouse ModelMediatingMolecularPhenotypeIn VivoResponseInnovationMutant Strains MiceReportingImpairmentGeneticDefectComplexLeadAffectInsightMutationSignal TransductionAutism Spectrum DisorderBrain RegionBrainAreaKnock-Out
Grant awards (38)
A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases$10,672,633
UG3 · FY2025 · TR · contact PI
Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss$1,479,388
R01 · FY2025 · HD · contact PI
Yale Diagnostic Center of Excellence for Undiagnosed Diseases$837,484
U01 · FY2025 · NS · contact PI
A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases$10,834,632
UG3 · FY2024 · TR · contact PI
Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss$1,479,765
R01 · FY2024 · HD · contact PI
Yale Diagnostic Center of Excellence for Undiagnosed Diseases$837,484
U01 · FY2024 · NS · contact PI
A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases$5,019,038
UG3 · FY2023 · TR · contact PI
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models$610,951
R01 · FY2023 · MH · contact PI
Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss$1,509,604
R01 · FY2022 · HD · contact PI
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models$609,966
R01 · FY2022 · MH · contact PI
Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss$1,524,247
R01 · FY2021 · HD · contact PI
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models$602,074
R01 · FY2021 · MH · contact PI
Characterizing the (epi)genetics of oxytocin response in clinical and animal models$571,841
R01 · FY2021 · HD
Epigenetic Therapy and Prader-Willi Syndrome$555,703
R01 · FY2021 · HD · contact PI
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models$706,078
R01 · FY2020 · MH · contact PI
Characterizing the (epi)genetics of oxytocin response in clinical and animal models$615,523
R01 · FY2020 · HD
Epigenetic Therapy and Prader-Willi Syndrome$577,116
R01 · FY2020 · HD · contact PI
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models$651,282
R01 · FY2019 · MH · contact PI
Characterizing the (epi)genetics of oxytocin response in clinical and animal models$513,000
R01 · FY2019 · HD
Epigenetic Therapy and Prader-Willi Syndrome$395,303
R01 · FY2019 · HD · contact PI
Epigenetic Therapy and Prader-Willi Syndrome$165,579
R01 · FY2019 · HD · contact PI
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models$66,448
R01 · FY2019 · MH · contact PI
Characterizing the (epi)genetics of oxytocin response in clinical and animal models$592,986
R01 · FY2018 · HD
Epigenetic Therapy and Prader-Willi Syndrome$561,008
R01 · FY2018 · HD · contact PI
A novel paradigm to dissect the function connectivity in Shank3 autism model$227,321
R21 · FY2018 · HD · contact PI
A novel paradigm to dissect the function connectivity in Shank3 autism model$11,179
R21 · FY2018 · HD · contact PI
Characterizing the (epi)genetics of oxytocin response in clinical and animal models$656,021
R01 · FY2017 · HD
Epigenetic Therapy and Prader-Willi Syndrome$582,250
R01 · FY2017 · HD · contact PI
A novel paradigm to dissect the function connectivity in Shank3 autism model$195,800
R21 · FY2017 · HD · contact PI
Analysis of Shank3 Complete and Temporal and Spatial Specific Knockout Mice$425,202
R01 · FY2016 · MH · contact PI
Analysis of Shank3 Complete and Temporal and Spatial Specific Knockout Mice$425,202
R01 · FY2015 · MH · contact PI
A novel neural circuit analysis paradigm to model autism in mice$238,500
R21 · FY2015 · MH · contact PI
Therapeutic potential for Prader-Willi syndrome$224,550
R21 · FY2015 · HD · contact PI
Analysis of Shank3 Complete and Temporal and Spatial Specific Knockout Mice$425,202
R01 · FY2014 · MH · contact PI
A novel neural circuit analysis paradigm to model autism in mice$196,667
R21 · FY2014 · MH · contact PI
Therapeutic potential for Prader-Willi syndrome$188,400
R21 · FY2014 · HD · contact PI
Analysis of Shank3 Complete and Temporal and Spatial Specific Knockout Mice$408,192
R01 · FY2013 · MH · contact PI
Analysis of Shank3 Complete and Temporal and Spatial Specific Knockout Mice$481,448
R01 · FY2012 · MH · contact PI